A new treatment that might one day help all patients with haemophilia, including those that become resistant to existing therapies, has been developed by researchers at the University of Cambridge.
Innovation is about the application of new ideas, discoveries and inventions. The innovative and entrepreneurial spirit of the members of the University of Cambridge is enshrined in the University’s mission statement to contribute to society through the pursuit of education, learning and research at the highest international levels of excellence. The foundation for innovation is the steady supply of excellent ideas, of which there is an abundance at Cambridge. Ingenuity and creativity, alongside the fundamental research which underpins these ideas and combined with the constant exchange of ideas between academics and companies, governments and NGOs has been the recipe for this success.
Various mechanisms are in place to help our academics nurture future innovation. As well as dedicated departmental support structures, Cambridge Enterprise provides technology transfer, consultancy services and seed fund opportunities, and the Centre for Entrepreneurial Learning (CfEL) within the Judge Business School provides networking opportunities with peers. In addition, Cambridge-based initiatives physically embedded within the University such as ideaSpace provide hubs for entrepreneurs to develop ideas.
Cambridge spin-out Carrick Therapeutics raises $95 million in funding, representing the largest-ever early stage investment in a UK university spin-out company.
New study identifies four strategies and two key methods for scaling up social businesses in developing countries in order to meet the unmet needs of more than four billion people.
A smart material that switches back and forth between transparent and opaque could be installed in buildings or automobiles, potentially reducing energy bills by avoiding the need for costly air conditioning.